Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) reported Q1 EPS of ($1.02), $0.50 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Dicerna Pharmaceuticals, Inc. (DRNA) click here.